The document outlines the nursing process for patients receiving acetaminophen (Tylenol). It discusses assessing for allergies, liver or kidney disease, and concurrent medications. Potential nursing diagnoses include pain, risk for injury from toxicity, and deficient knowledge. The goals are for the patient to understand safe use, experience pain relief, and avoid toxicity. Nurses should monitor for liver or kidney issues, medication interactions, signs of infection or intolerance, and pain levels. Education includes safe administration, reporting side effects, and avoiding excess use. The outcome is evaluated by ensuring patient goals of understanding, pain relief and avoiding toxicity are met.
The document outlines the nursing process for patients receiving acetaminophen (Tylenol). It discusses assessing for allergies, liver or kidney disease, and concurrent medications. Potential nursing diagnoses include pain, risk for injury from toxicity, and deficient knowledge. The goals are for the patient to understand safe use, experience pain relief, and avoid toxicity. Nurses should monitor for liver or kidney issues, medication interactions, signs of infection or intolerance, and pain levels. Education includes safe administration, reporting side effects, and avoiding excess use. The outcome is evaluated by ensuring patient goals of understanding, pain relief and avoiding toxicity are met.
The document outlines the nursing process for patients receiving acetaminophen (Tylenol). It discusses assessing for allergies, liver or kidney disease, and concurrent medications. Potential nursing diagnoses include pain, risk for injury from toxicity, and deficient knowledge. The goals are for the patient to understand safe use, experience pain relief, and avoid toxicity. Nurses should monitor for liver or kidney issues, medication interactions, signs of infection or intolerance, and pain levels. Education includes safe administration, reporting side effects, and avoiding excess use. The outcome is evaluated by ensuring patient goals of understanding, pain relief and avoiding toxicity are met.
Prior to administration: • Pain, related to ineffective response to drug • Obtain complete health history including • Risk for Injury (hepatic toxicity), related to allergies, drug history and possible drug adverse effects of drug interactions. • Deficient Knowledge, related to drug action • Obtain history of liver disease. and side effects • Assess history of pain or fever. • Obtain concurrent use of anticoagulants. • Obtain intolerance to ASA. Planning: Patient Goals and Expected Outcomes The patient will: • Demonstrate an understanding of safe self-administration of medication. • Demonstrate relief of pain. • Remain free of evidence of hepatic toxicity. Implementation Interventions and (Rationales) Patient Education/Discharge Planning *Monitor for evidence of liver dysfunction Advise patient: (due to acetaminophen accumulation, and • to abstain from alcohol while taking this resulting liver damage). medication. • to report signs of liver dysfunction including jaundice, itching, fatigue. *Monitor renal function tests and intake and Advise patient: output (due to the ability of acetaminophen to • that lab tests to assess renal function may impair renal function as a result of toxic levels.) be necessary to prevent renal tubular necrosis. • to notify health care provider if changes in urinary output occurs. *Monitor concurrent medication use. Advise patient : (Be alert to all other medications that contain • to avoid taking any other OTC medication acetaminophen especially in combination with unless ordered by health care provider. narcotic pain reliever to avoid toxic levels. • to read directions carefully when using Contraindicated for use with warfarin due to acetaminophen suspension and drops. the mechanism of inhibition of warfarin • not to exceed recommended daily dose of metabolism, which causes warfarin to medication. accumulate at high levels.) *Observe for intolerance to ASA for possible *Instruct patient to report any itching, skin rash, cross-hypersensivity to acetaminophen. or difficulty breathing. *Monitor for signs of infection, including *Instruct patient to report signs of infection, complete blood count and platelet count. generalized mild muscular pain, and headache. (Acetominophen’s effects may mask infection.) *Monitor pain level (to determine effectiveness *Instruct patient to report changes in pain level of drug therapy.) to health care provider. *Monitor blood sugar in patients with diabetes *Advise patient that this medication may cause mellitus. (Acetaminophen may decrease insulin hypoglycemia. needs.) Evaluation of Outcome Criteria Evaluate the effectiveness of drug therapy by confirming that patient goals and expected outcomes have been met (see “Planning”).